T1	Outcomes 65 90	efficacy of immunotherapy
T2	Outcomes 182 227	effectiveness of specific immunotherapy (SIT)
T3	Outcomes 758 805	median daily inhaled corticosteroid (ICS) dose,
T4	Outcomes 918 939	median daily ICS dose
T5	Outcomes 1133 1171	induction of T regulatory lymphocytes.
T6	Outcomes 1534 1581	early clinical and immunological effects of SIT
T7	Outcomes 1619 1638	'adverse' influence